BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2423822)

  • 1. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
    Mathé G
    Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
    Bruley-Rosset M; Payelle B; Rappaport H
    J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopharmacological properties of tuftsin and of some analogues.
    Florentin I; Martinez J; Maral J; Pelletier M; Chung V; Roch-Arveiller M; Bruley-Rosset M; Giroud JP; Winternitz F; Mathé G
    Ann N Y Acad Sci; 1983; 419():177-91. PubMed ID: 6424534
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tuftsin].
    Mücke D
    Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitro.
    Spirer Z; Zakuth V; Tzehoval E; Dagan S; Fridkin M; Golander A; Melamed I
    J Clin Lab Immunol; 1989 Jan; 28(1):27-31. PubMed ID: 2786082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myśliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
    Suzuki R; Suzuki S; Igarashi M; Kumagai K
    J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion.
    Dagan S; Tzehoval E; Tartakovsky B; Fridkin M; Feldman M
    J Biol Response Mod; 1988 Dec; 7(6):546-58. PubMed ID: 3265146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
    Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
    J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The action of tuftsin on the reaction of macrophage-suppressor formation in vitro and in vivo].
    Voevodin DA
    Biull Eksp Biol Med; 1988 Nov; 106(11):559-61. PubMed ID: 2973818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of human granulocyte phagocytosis stimulation by tuftsin.
    Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
    J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
    Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
    J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
    Dagan S; Tzehoval E; Fridkin M; Feldman M
    J Biol Response Mod; 1987 Dec; 6(6):625-36. PubMed ID: 3502474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.
    Kubo S; Rodriguez T; Roh MS; Oyedeji C; Romsdahl MM; Nishioka K
    Hepatology; 1994 Apr; 19(4):1044-9. PubMed ID: 8138244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuftsin: its chemistry, biology, and clinical potential.
    Fridkin M; Najjar VA
    Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.